ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,189.92
0.48%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. ImmunoGen Inc (IMGN)

  7. ImmunoGen Inc (IMGN) 뉴스

IMGN ImmunoGen Inc

31.235
0.00 (0.00%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
ImmunoGen Inc IMGN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 31.235 09:00:00
개장가 저가 고가 종가 전일 종가
31.235 31.235
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/02/202406:15EDGAR2Form 15-12G - Securities registration termination [Section..
15/02/202407:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:33EDGAR2Form S-8 POS - Securities to be offered to employees in..
12/02/202423:32EDGAR2Form 25-NSE - Notification filed by national security..
12/02/202421:52EDGAR2Form 8-K - Current report
12/02/202421:37PRNUSAbbVie Completes Acquisition of ImmunoGen
08/02/202421:08EDGAR2Form 8-K - Current report
07/02/202421:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/02/202411:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202411:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202411:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202411:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202411:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202411:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202411:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202411:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202411:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202411:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202411:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202411:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:10EDGAR2Form 144 - Report of proposed sale of securities
06/02/202406:09EDGAR2Form 144 - Report of proposed sale of securities
06/02/202406:08EDGAR2Form 144 - Report of proposed sale of securities
06/02/202406:07EDGAR2Form 144 - Report of proposed sale of securities
02/02/202406:30BWImmunoGen Announces Inducement Grants Under Nasdaq Listing..
01/02/202406:12EDGAR2Form 8-K - Current report
30/01/202407:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/01/202407:00EDGAR2Form 8-K - Current report
25/01/202406:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/01/202406:55EDGAR2Form 8-K - Current report
19/01/202408:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202406:20EDGAR2Form 144 - Report of proposed sale of securities
13/01/202401:10PRNUSKuehn Law Encourages PXD, IMGN, HA and ICVX Investors to..

최근 히스토리

NASDAQ
IMGN
ImmunoGen
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유